This condition triggers secondary hyperparathyroidism, characterized by elevated parathyroid hormone (PTH) levels, which in turn stimulate osteoclastic bone resorption to maintain serum calcium concentrations [30]. The gene discussed is PTH; the disease is secondary hyperparathyroidism.